Literature DB >> 32888639

Addressing Comorbidities in Heart Failure: Hypertension, Atrial Fibrillation, and Diabetes.

Aakash Bavishi1, Ravi B Patel2.   

Abstract

Heart failure (HF) is a growing global epidemic and an increasingly cumbersome burden on health care systems worldwide. As such, optimal management of existing comorbidities in the setting of HF is particularly important to prevent disease progression, reduce HF hospitalizations, and improve quality of life. In this review, the authors address 3 key comorbidities commonly associated with HF: hypertension, atrial fibrillation, and diabetes mellitus. They comprehensively describe the epidemiology, management, and emerging therapies in these 3 disease states as they relate to the overall HF syndrome.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atrial fibrillation; Diabetes mellitus; Heart failure; Hypertension; Prevalence

Mesh:

Year:  2020        PMID: 32888639      PMCID: PMC7479642          DOI: 10.1016/j.hfc.2020.06.005

Source DB:  PubMed          Journal:  Heart Fail Clin        ISSN: 1551-7136            Impact factor:   3.179


  113 in total

Review 1.  Obstructive sleep apnea and heart failure: pathophysiologic and therapeutic implications.

Authors:  Takatoshi Kasai; T Douglas Bradley
Journal:  J Am Coll Cardiol       Date:  2011-01-11       Impact factor: 24.094

2.  Long-term trends in the incidence of and survival with heart failure.

Authors:  Daniel Levy; Satish Kenchaiah; Martin G Larson; Emelia J Benjamin; Michelle J Kupka; Kalon K L Ho; Joanne M Murabito; Ramachandran S Vasan
Journal:  N Engl J Med       Date:  2002-10-31       Impact factor: 91.245

3.  Dofetilide in patients with congestive heart failure and left ventricular dysfunction: safety aspects and effect on atrial fibrillation. The Danish Investigators of Arrhythmia and Mortality on Dofetilide (DIAMOND) Study Group.

Authors:  M Møller; C T Torp-Pedersen; L Køber
Journal:  Congest Heart Fail       Date:  2001 May-Jun

4.  Global Public Health Burden of Heart Failure.

Authors:  Gianluigi Savarese; Lars H Lund
Journal:  Card Fail Rev       Date:  2017-04

5.  A randomized controlled trial of catheter ablation versus medical treatment of atrial fibrillation in heart failure (the CAMTAF trial).

Authors:  Ross J Hunter; Thomas J Berriman; Ihab Diab; Ravindu Kamdar; Laura Richmond; Victoria Baker; Farai Goromonzi; Vinit Sawhney; Edward Duncan; Stephen P Page; Waqas Ullah; Beth Unsworth; Jamil Mayet; Mehul Dhinoja; Mark J Earley; Simon Sporton; Richard J Schilling
Journal:  Circ Arrhythm Electrophysiol       Date:  2014-01-01

6.  Metformin in Diabetic Patients with Heart Failure: Safe and Effective?

Authors:  Ijeoma Ananaba Ekeruo; Amirreza Solhpour; Heinrich Taegtmeyer
Journal:  Curr Cardiovasc Risk Rep       Date:  2013-12-01

Review 7.  Comorbidity of atrial fibrillation and heart failure.

Authors:  Liang-Han Ling; Peter M Kistler; Jonathan M Kalman; Richard J Schilling; Ross J Hunter
Journal:  Nat Rev Cardiol       Date:  2015-12-10       Impact factor: 32.419

8.  Efficacy and Safety of Novel Oral Anticoagulants in Patients With Atrial Fibrillation and Heart Failure: A Meta-Analysis.

Authors:  Gianluigi Savarese; Robert P Giugliano; Giuseppe M C Rosano; John McMurray; Giulia Magnani; Gerasimos Filippatos; Santo Dellegrottaglie; Lars H Lund; Bruno Trimarco; Pasquale Perrone-Filardi
Journal:  JACC Heart Fail       Date:  2016-09-07       Impact factor: 12.035

Review 9.  Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation: Vicious Twins.

Authors:  Dipak Kotecha; Carolyn S P Lam; Dirk J Van Veldhuisen; Isabelle C Van Gelder; Adriaan A Voors; Michiel Rienstra
Journal:  J Am Coll Cardiol       Date:  2016-11-15       Impact factor: 24.094

10.  Atrial Fibrillation Begets Heart Failure and Vice Versa: Temporal Associations and Differences in Preserved Versus Reduced Ejection Fraction.

Authors:  Rajalakshmi Santhanakrishnan; Na Wang; Martin G Larson; Jared W Magnani; David D McManus; Steven A Lubitz; Patrick T Ellinor; Susan Cheng; Ramachandran S Vasan; Douglas S Lee; Thomas J Wang; Daniel Levy; Emelia J Benjamin; Jennifer E Ho
Journal:  Circulation       Date:  2016-01-08       Impact factor: 29.690

View more
  2 in total

1.  Time to Death and Its Determinant Factors Among Patients With Chronic Heart Failure in Northwest Ethiopia: A Retrospective Study at Selected Referral Hospitals.

Authors:  Yikeber Abebaw Moyehodie; Mitiku Wale Muluneh; Alebachew Taye Belay; Setegn Muche Fenta
Journal:  Front Cardiovasc Med       Date:  2022-05-06

2.  History of Heart Failure in Patients Hospitalized Due to COVID-19: Relevant Factor of In-Hospital Complications and All-Cause Mortality up to Six Months.

Authors:  Mateusz Sokolski; Konrad Reszka; Tomasz Suchocki; Barbara Adamik; Adrian Doroszko; Jarosław Drobnik; Joanna Gorka-Dynysiewicz; Maria Jedrzejczyk; Krzysztof Kaliszewski; Katarzyna Kilis-Pstrusinska; Bogusława Konopska; Agnieszka Kopec; Anna Larysz; Weronika Lis; Agnieszka Matera-Witkiewicz; Lilla Pawlik-Sobecka; Marta Rosiek-Biegus; Justyna M Sokolska; Janusz Sokolowski; Anna Zapolska-Tomasiewicz; Marcin Protasiewicz; Katarzyna Madziarska; Ewa A Jankowska
Journal:  J Clin Med       Date:  2022-01-03       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.